Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukocyte Activation Disorder”

31 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 31 results

Not applicableStudy completedNCT00038675
What this trial is testing

Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate

Who this might be right for
Chronic Myelomonocytic LeukemiaChronic Myeloid LeukemiaPolycythemia Vera+2 more
M.D. Anderson Cancer Center 125
Not applicableStudy completedNCT00001353
What this trial is testing

Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT01967459
What this trial is testing

Effects Vitamin D Suppletion on Postprandial Leukocyte Activation

Who this might be right for
AtherosclerosisOxidative StressLeukocyte Activation Disorder
Sint Franciscus Gasthuis 24
Testing effectiveness (Phase 2)Study completedNCT00109707
What this trial is testing

Oral AMN107 in Adults With Chronic Myelogenous Leukemia (CML) or Other Hematologic Malignancies

Who this might be right for
Chronic Myelogenous LeukemiaAcute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)Hypereosinophilic Syndrome+1 more
Novartis Pharmaceuticals 507
Early research (Phase 1)Study completedNCT01883869
What this trial is testing

Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor

Who this might be right for
PneumoniaCommunity Acquired PneumoniaHospital Acquired Pneumonia+1 more
University of Kentucky 60
Not applicableStudy completedNCT02130505
What this trial is testing

Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes

Who this might be right for
AtherosclerosisLeukocyte Activation DisorderType 2 Diabetes Mellitus+1 more
Sint Franciscus Gasthuis 51
Testing effectiveness (Phase 2)Study completedNCT00171912
What this trial is testing

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

Who this might be right for
Hypereosinophilic SyndromeSystemic MastocytosisChronic Myelomonocytic Leukemia+1 more
Novartis Pharmaceuticals 38
Early research (Phase 1)Study completedNCT00244946
What this trial is testing

Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Barbara Ann Karmanos Cancer Institute 15
Not applicableStudy completedNCT05059431
What this trial is testing

The Effect of Human Prostate Tissue on Platelet Activation

Who this might be right for
Prostate HyperplasiaCoagulation; IntravascularThrombotic Disorder
Tri-Service General Hospital 8
Early research (Phase 1)Study completedNCT01875601
What this trial is testing

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors

Who this might be right for
Solid TumorsBrain TumorsSarcoma+2 more
National Cancer Institute (NCI) 16
Not applicableUnknownNCT04307979
What this trial is testing

Acute High Fat Bulletproof Coffee vs Black Coffee on Metabolism, Inflammation and Cognitive Function in Healthy Adults

Who this might be right for
LeukocytosisTriglyceridesCognitive Function+1 more
University of British Columbia 20
Early research (Phase 1)Looking for participantsNCT04097561
What this trial is testing

Safety of Belimumab in People With Idiopathic CD4 Lymphopenia and Autoantibodies (Phoebe)

Who this might be right for
Idiopathic CD4 Lymphopenia
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT01797016
What this trial is testing

Platelet Leukocyte Aggregates in Acute Cardiac Syndrome vs Healthy Volunteers

Who this might be right for
Myocardial Infarction
Ziv Hospital 59
Early research (Phase 1)Study completedNCT01241903
What this trial is testing

Early Use of Rosuvastatin in Acute Coronary Syndromes: Targeting Platelet-Leukocyte Interactions

Who this might be right for
Acute Coronary SyndromeAngioplasty, Transluminal, Percutaneous CoronaryHydroxymethylglutaryl-CoA Reductase Inhibitors+1 more
Susan Smyth 54
Not applicableStudy completedNCT02775045
What this trial is testing

Eosinophil β1 Integrin Activation as a Biomarker for Eosinophilic Esophagitis

Who this might be right for
Eosinophilic Esophagitis
University of Wisconsin, Madison 28
Testing effectiveness (Phase 2)Study completedNCT00154388
What this trial is testing

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

Who this might be right for
Life Threatening Diseases
Novartis Pharmaceuticals 185
Not applicableStudy completedNCT02376738
What this trial is testing

Regional Activation of Leukocytes in Coronary Artery Disease

Who this might be right for
InflammationCoronary Artery Disease
Sint Franciscus Gasthuis 97
Early research (Phase 1)Study completedNCT00817752
What this trial is testing

Ashwagandha: Effects on Stress, Inflammation and Immune Cell Activation

Who this might be right for
InflammationCancerAutoimmune Diseases
National University of Natural Medicine 25
Not applicableLooking for participantsNCT07125079
What this trial is testing

Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy.

Who this might be right for
ARDS (Acute Respiratory Distress Syndrome)
University of Pennsylvania 36
Not applicableLooking for participantsNCT02760238
What this trial is testing

Myeloproliferative Neoplasms (MPNs) Patient Registry

Who this might be right for
Primary MyelofibrosisPolycythemia VeraEssential Thrombocythemia+7 more
University Health Network, Toronto 5,000
Load More Results